Potential Companies with which we will be
working:
1- Puncture-proof surgical gloves
2- Low cost long shelf life synthetic biosensors for diagnostics and high
throughput drug screening
3- Low cost portable instrumentation for detection of chemical and
biological agents for both military and mass market uses
4- Low cost process to manufacture quantum dot optical amplifiers
5- Optical tweezers to manipulate biological and other molecules
6- Angstroms thick programmable frequency electromagnetic interference (EMI)
shielding with shielding effectiveness of 80 db (99.99% attenuation) and 120
db (99.9999% attenuation) for frequencies above 100 GHz
7- Stimuli-responsive insulin delivery systems - oral and nasal delivery to
diabetic patients with higher absorptivity and bioavailability; prevents
macrophage digestion, and releases insulin in the body only when the blood
sugar level is high
8- Handheld explosive detection device
9- Lower cost nanoparticle ZnO2 and TiO2 (and other metallics and metallic
oxides) production than Nanophase's patented process
10- Inorganic buckyballs and nanotubes for military applications
11- Nanoparticle for coatings: broad spectrum of luminiscent colors (safety
applications), anti-fouling capabilities (marine and naval applications),
fuel efficiency (military and aviation
11- Portable Avian
Flu detection instrumentation with diagnosis in one hour or less
12- Universal
Avian Flu vaccine
13- Lightweight Body
armor
Those are just a sample
of the opportunities we will be working with. Some of them are early stage
and some of them are later stage. All have proof of concept already
established. There are
other opportunities as well but these will require some work to bring the
business plan up to the level of quality for funding but that should not
take long.
These companies all produce real product to sell. They do not just have IP.
Most will be producing revenues within 2 years and 3 companies are already
producing revenues. This is of interest to note because most business
experts predict no commercial application and revenues in nanotechnology for
5-10 years.
As you can see, these companies span a variety of
stages. Some of these companies have technology applicable in other markets.
Nanotechnology is
inherently diversified risk because of the diverse industries, applications
and markets it affects.
Seraphima
Ventures
